Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
Already had your visit
[5] Its expansion into tendon, ligament, muscle, and bone research came later, largely from the same group of investigators
Ready for Real Change
While some trials are registered on ClinicalTrials.gov, results remain limited or unpublished as of July 2026
Table 11: Results at Week 26 in a Trial Comparing TRESIBA to Insulin Glargine U-100 in Adult Patients with Type 2 Diabetes Mellitus on OAD(s)* *OAD: oral antidiabetic agent **The change from baseline to end of treatment visit in HbA1c was analyzed using ANOVA with treatment, region, sex, and anti-diabetic treatment at screening as fixed effects, and age and baseline HbA1c as covariates
.png)
US$ 20.93
US$ 27.50
US$ 20.03
US$ 25.96
US$ 25.73
US$ 27.43
US$ 22.25
